These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
429 related items for PubMed ID: 22513795
1. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity. Haase R, Elsner K, Merkel N, Stiefel M, Mauz-Körholz C, Kramm CM, Körholz D. Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795 [Abstract] [Full Text] [Related]
2. MTHFR 677 (C-->T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95. Seidemann K, Book M, Zimmermann M, Meyer U, Welte K, Stanulla M, Reiter A. Ann Hematol; 2006 May; 85(5):291-300. PubMed ID: 16463153 [Abstract] [Full Text] [Related]
3. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis. Schmeling H, Biber D, Heins S, Horneff G. J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884 [Abstract] [Full Text] [Related]
4. [Association between the methylenetetrahydrofolate reductase gene polymorphisms and haplotype with toxicity response of high dose methotrexate chemotherapy]. Liao QC, Li XL, Liu ST, Zhang Y, Li TY, Qiu JC. Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jul; 33(7):735-9. PubMed ID: 22968027 [Abstract] [Full Text] [Related]
5. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. Schnakenberg E, Mehles A, Cario G, Rehe K, Seidemann K, Schlegelberger B, Elsner HA, Welte KH, Schrappe M, Stanulla M. BMC Med Genet; 2005 May 27; 6():23. PubMed ID: 15921520 [Abstract] [Full Text] [Related]
6. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants. D'Angelo V, Ramaglia M, Iannotta A, Crisci S, Indolfi P, Francese M, Affinita MC, Pecoraro G, Napolitano A, Fusco C, Oreste M, Indolfi C, Casale F. Cancer Chemother Pharmacol; 2011 Nov 27; 68(5):1339-46. PubMed ID: 21590445 [Abstract] [Full Text] [Related]
7. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Aplenc R, Thompson J, Han P, La M, Zhao H, Lange B, Rebbeck T. Cancer Res; 2005 Mar 15; 65(6):2482-7. PubMed ID: 15781665 [Abstract] [Full Text] [Related]
8. Methylenetetrahydrofolate reductase gene polymorphisms c.677C/T and c.1298A/C are not associated with open angle glaucoma. Mabuchi F, Tang S, Kashiwagi K, Yamagata Z, Iijima H, Tsukahara S. Mol Vis; 2006 Jul 07; 12():735-9. PubMed ID: 16862068 [Abstract] [Full Text] [Related]
10. Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia. Kałużna E, Strauss E, Zając-Spychała O, Gowin E, Świątek-Kościelna B, Nowak J, Fichna M, Mańkowski P, Januszkiewicz-Lewandowska D. Eur J Pharmacol; 2015 Dec 15; 769():93-9. PubMed ID: 26528799 [Abstract] [Full Text] [Related]
11. 667C>T and 1298A>C polymorphisms of MTHFR do not predict response to methotrexate in patients with gestational trophoblastic neoplasia. Lasecka L, Dixon PH, Molokhia M, Sharma N, Schleh A, Wang CM, Steel JH, Seckl MJ, Savage PM, Fisher RA. Gynecol Oncol; 2011 Dec 15; 123(3):605-9. PubMed ID: 21920590 [Abstract] [Full Text] [Related]
12. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia. Erčulj N, Kotnik BF, Debeljak M, Jazbec J, Dolžan V. Leuk Lymphoma; 2012 Jun 15; 53(6):1096-104. PubMed ID: 22074251 [Abstract] [Full Text] [Related]
14. MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients. Chiusolo P, Reddiconto G, Farina G, Mannocci A, Fiorini A, Palladino M, La Torre G, Fianchi L, Sorà F, Laurenti L, Leone G, Sica S. Leuk Res; 2007 Dec 15; 31(12):1669-74. PubMed ID: 17512587 [Abstract] [Full Text] [Related]
15. Investigation of the association between 677C>T and 1298A>C 5,10-methylenetetra- hydrofolate reductase gene polymorphisms and normal-tension glaucoma. Woo SJ, Kim JY, Kim DM, Park SS, Ko HS, Yoo T. Eye (Lond); 2009 Jan 15; 23(1):17-24. PubMed ID: 17618244 [Abstract] [Full Text] [Related]
16. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia. Eissa DS, Ahmed TM. Blood Coagul Fibrinolysis; 2013 Mar 15; 24(2):181-8. PubMed ID: 23183238 [Abstract] [Full Text] [Related]
17. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Kantar M, Kosova B, Cetingul N, Gumus S, Toroslu E, Zafer N, Topcuoglu N, Aksoylar S, Cinar M, Tetik A, Eroglu Z. Leuk Lymphoma; 2009 Jun 15; 50(6):912-7. PubMed ID: 19391036 [Abstract] [Full Text] [Related]
19. [Relationship between the methylenetetrahydrofolate reductase gene polymorphism and adverse reactions of high-dose methotrexate in children with acute lymphocytic leukemia]. Zheng MM, Yue LJ, Chen XW, Wen FQ, Li CG, Yang CL, Xie C, Ding H. Zhongguo Dang Dai Er Ke Za Zhi; 2013 Mar 15; 15(3):201-6. PubMed ID: 23498762 [Abstract] [Full Text] [Related]
20. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia. Tantawy AA, El-Bostany EA, Adly AA, Abou El Asrar M, El-Ghouroury EA, Abdulghaffar EE. Blood Coagul Fibrinolysis; 2010 Jan 15; 21(1):28-34. PubMed ID: 19923983 [Abstract] [Full Text] [Related] Page: [Next] [New Search]